Sponsor Pipeline

Well Cell Global Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07187479
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney…		 date change Primary completion pushed: 2026-06 -> 2026-12
2026-08-05 NCT07187479
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney…		 date change Completion pushed: 2026-06 -> 2026-12
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07187479 Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney… Chronic Kidney Disease (Stages 4 and 5) Recruiting
Disease Areas
Type 2 Diabetes (1) Diabetes (1) Chronic Kidney Disease (1)
Get alerts when Well Cell Global's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free